Clinical Trials
8 trialsNCT05417971 2026-04-16
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Northside Hospital, Inc.
Recruiting
NCT03016806 2025-10-10
Umbilical Cord Blood Transplantation From Unrelated Donors
University of Rochester
Recruiting
NCT06175702 2023-12-19
LALPh2022
PETHEMA Foundation
Not yet recruiting
NCT01316549 2021-10-04
HCT
University of California, San Francisco
Completed
NCT03609814 2021-10-04
Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
University of California, San Francisco
Completed
NCT01540812 2020-03-09
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
PETHEMA Foundation
Completed
NCT02328950 2016-02-17
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
Fujian Medical University
Unknown
NCT02156726 2014-06-05
Q-lite
Czech CLL Study Group
Unknown